Stock Report

All about this stock under one free report Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Elder Pharmaceuticals Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ELDERPHARM | BSE: 532322

₹38.00

up-down-arrow ₹1.80 (4.97%)

As on 12-Sep-2016IST

Market cap

info icon

₹78 Cr

Revenue (TTM)

info icon

₹633 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -31.41 -76.03 -59.65 -37.87 -19.67
EBIT 19.69 -47.82 -407.41 -211.37 -217.18
Net Profit 29.84 31.98 27.84 -188.63 -200.93
EPS 29.84 31.98 -107.93 -- -200.63
Book Value -- -- 0.53 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMJun-14Jun-13
EBIT-Margin info -----39.92-11.4313.97
Net Margin info -----12.35-0.634.92
Return on equity info -----61.43-0.8511.21
Return on Capital info ------15.0813.31
Return on Assets info -----3.70-0.273.67
Debt to Equity (x) info ----0.581.101.75

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
15.08
13.31
11.66
11.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-61.43

Lower than Peers by 72.29

Profit after tax / Average Net worth * 100

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-61.43
-0.85
11.21
10.86
11.44
Peer Median
10.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-3.70

Lower than Peers by 10.44

Profit after tax / Average Total assets * 100

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-3.70
-0.27
3.67
3.86
4.33
Peer Median
6.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-39.92

Lower than Peers by 52.61

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-39.92
-11.43
13.97
12.36
14.69
Peer Median
12.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-12.35

Lower than Peers by 21.22

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-12.35
-0.63
4.92
5.31
6.52
Peer Median
8.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
2.92
7.65
7.90
9.46
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-41.01

Lower than Peers by 49.15

Year on year growth in net sales

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-41.01
-38.54
22.99
38.28
33.77
Peer Median
8.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-385.73

Lower than Peers by 402.97

Year on year growth in operating profit (EBIT)

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-385.73
-150.30
--
16.40
40.45
Peer Median
17.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

27.84

Higher than Peers by 10.99

Year on year growth in profit after tax

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
27.84
-107.93
14.02
13.71
34.57
Peer Median
16.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-390.57

Lower than Peers by 401.17

Year on year growth in earnings per share

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-390.57
-107.93
14.02
12.51
19.13
Peer Median
10.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
0.53
9.80
11.09
31.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.58

Higher than Peers by 0.53

Total debt / Net worth

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
0.58
1.10
1.75
1.54
1.43
Peer Median
0.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.48

--

(Short term borrowings / Net worth)

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
0.48
0.34
0.58
0.56
0.51
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.78

Lower than Peers by 0.94

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
0.78
0.92
0.88
1.26
1.43
Peer Median
1.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.62

Lower than Peers by 0.56

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
0.62
0.81
0.65
0.85
1.02
Peer Median
1.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

0.63

Lower than Peers by 7.23

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
0.63
1.02
1.67
1.90
2.23
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

28.49

Higher than Peers by 2.70

Debtors outstanding / Net Sales * 100

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
28.49
16.42
24.25
25.57
29.26
Peer Median
25.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.29

Lower than Peers by 0.37

Sales / Average Total Assets

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
0.29
0.42
0.74
0.72
0.66
Peer Median
0.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
101.58
81.60
84.64
89.44
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
67.21
59.37
72.55
72.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
61.48
45.48
36.03
34.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
107.30
95.49
121.15
127.47
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
--
8.12
9.62
12.47
Peer Median
39.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.12

Lower than Peers by 4.09

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
0.12
0.58
0.87
0.99
1.27
Peer Median
4.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
--
--
--
0.89
0.77
Peer Median
0.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-1.87

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
-1.87
-13.97
6.24
7.19
8.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

78

Lower than Peers by 7,306

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Jun-14
Jun-13
Mar-12
Mar-11
Elder Pharmaceuticals
78
447
669
695
801
Peer Median
7,384
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...